SavedAdd your journal

Journals / Osmangazi Tıp Dergisi / 2026 / Cilt: 48 Sayı: 1

Evaluation of Sexual Dysfunction in Patients with Hidradenitis Suppurativa: Do Disease Stage and Lesion Location Affect Sexual Function?

Hidradenitis Suppurativa Tanılı Hastalarda Cinsel Fonksiyon Bozukluğunun Değerlendirilmesi: Hastalığın Evresi ve Lezyon Yerleşim Yeri Cinsel Fonksiyonu Etkiliyor mu?

Tubanur Çetinarslan(MANİSA CELÂL BAYAR ÜNİVERSİTESİ)0000-0002-2847-9127
Şule Yıldız Sağcan Tercan(MANİSA CELÂL BAYAR ÜNİVERSİTESİ)0009-0002-4539-0383
Ali Can Albaz(MANİSA CELÂL BAYAR ÜNİVERSİTESİ)0000-0002-7725-1241
Beyhan Özyurt(MANİSA CELÂL BAYAR ÜNİVERSİTESİ)0000-0001-5377-4593
Aylin Türel Ermertcan(MANİSA CELÂL BAYAR ÜNİVERSİTESİ)0000-0001-7720-5491
Pages
103–113
Publication Date
2025-12-15
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This can be explained by the fact that women may experience more pressure to change their behavior based on physical appearance and that body image in women has a direct link to sexual life.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hidradenitis suppurativa (HS) is a chronic, inflammatory, and recurrent skin disease of the hair follicle.
📊
Key Findings & Data:A total of 46 patients (30 males and 16 females) and 81 healthy controls (44 males and 37 females) were included in the study.
💡
Conclusion & Impact:This can be explained by the fact that women may experience more pressure to change their behavior based on physical appearance and that body image in women has a direct link to sexual life.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:hidradenitis suppurativa · cinsel işlev bozukluğu · seksüel disfonksiyon

Abstract

Hidradenitis suppurativa (HS) is a chronic, inflammatory, and recurrent skin disease of the hair follicle. HS disrupts sexual function in both women and men.In this prospective study, the presence of sexual dysfunction (SD) was investigated in female patients with HS using the Female Sexual Function Index (FSFI) and in male patients using the International Index of Erectile Function (IIEF). Both genders were compared with a healthy control group. A total of 46 patients (30 males and 16 females) and 81 healthy controls (44 males and 37 females) were included in the study. SD was present in 81.3% (n=13) of female patients, while it was present in 29.7% (n=11) of female controls (p=0.001). In female patients with HS compared to the healthy control group; significant decreases were found in sexual desire (p<0.005), sexual arousal (p<0.001), lubrication (p=0.008), orgasm (p<0.001), and satisfaction (p<0.001) scores. SD was present in 20.0% (n=6) of male patients. SD was significantly more common in male patients with involvement of the gluteal region than in those without (p=0.005). According to Hurley stage in males, sexual desire was significantly lower in Hurley stage 3 compared to other stages (p=0.02). Sexual life problems are quite common in patients with HS compared to healthy individuals. In our study, we found that SD was associated with disease severity and lesion location, particularly in male patients. Furthermore, the frequency of SD in female patients (81.3%) was higher in our study compared to the healthy control group (0% in the male control group and 29.7% in the female control group) compared to male patients (20%). This can be explained by the fact that women may experience more pressure to change their behavior based on physical appearance and that body image in women has a direct link to sexual life.

Özet

Hidradenitis süpürativa (HS), kıl folikülünün kronik, inflamatuar, tekrarlayan bir deri hastalığıdır. HS’nin hem kadın hem erkek bireylerde cinsel fonksiyonu bozduğuna dair literatürde yayınlar mevcuttur. Bu prospektif çalışmada HS’li kadın hastalarda cinsel fonksiyon bozukluğunun (seksüel disfonksiyon, SD) varlığı Kadın Cinsel İşlev Ölçeği (FSFI) kullanılarak, erkek hastalarda ise Uluslarası Erektil İşlev Formu (IIEF) kullanılarak araştırılmış ve sağlıklı kontrol grubu ile her iki cinsiyette ayrı olarak karşılaştırılmıştır. Çalışmaya toplam 46 hasta (30 erkek ve 16 kadın) ve 81 sağlıklı kontrol (44 erkek ve 37 kadın) dahil edildi. Kadın hastalarda SD %81.3 (n=13) hastada varken, kadın kontrol grubunda %29.7 (n=11) hastada vardı (p=0.001). HS tanılı kadın hastalarda, sağlıklı kadın kontrol grubuna kıyasla; cinsel istek (p<0.005), cinsel uyarılma (p<0.001), lubrikasyon (p=0.008), orgazm (p<0.001) ve memnuniyet (p<0.001) skorlarının tümünde anlamlı düşüklük saptandı. Erkek hastalarda SD %20.0 (n=6) hastada vardı. Erkek hastalarda SD gluteal bölgede tutulumu olanlarda olmayanlara göre anlamlı olarak daha fazla izlendi (p=0.005). Erkeklerde Hurley evresine göre bakıldığında; Hurley Evre 3 olanlarda cinsel istek diğer evrelere göre anlamlı olarak daha düşüktü (p=0.02). HS'li hastalarda cinsel yaşam sorunları sağlıklı bireylere göre oldukça sıktır. Çalışmamızda da SD’nin özellikle erkek hastalarda hastalığın şiddeti ve lezyon yerleşim yeri ile ilişkili olduğunu bulduk. Ayrıca çalışmamızda erkek hastalara kıyasla (%20) kadın hastalarda SD sıklığı (%81.3) sağlıklı kontrol grubuna göre (erkek kontrol grubunda 0%, kadın kontrol grubunda %29.7) daha fazlaydı. Bu durum kadınların fiziksel görünüme bağlı olarak davranışlarını değiştirme konusunda daha fazla baskı yaşayabilmeleri ve kadınlarda beden imajının cinsel yaşamla doğrudan bağlantısı olması ile açıklanabilir.

🔖

Cite This Article

Çetinarslan, T., Tercan, Ş. Y. S., Albaz, A. C., Özyurt, B., Ermertcan, A. T. (2025). Evaluation of Sexual Dysfunction in Patients with Hidradenitis Suppurativa: Do Disease Stage and Lesion Location Affect Sexual Function?. Osmangazi Tıp Dergisi, Cilt: 48 Sayı: 1, 103–113. https://doi.org/10.20515/otd.1801972

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (59)

  1. Sabat R, Alavi A, Wolk K, Wortsman X, McGrath B, Garg A, Szepietowski JC. Hidradenitis suppurativa. Lancet. 2025 Feb 1;405(10476):420-438.
  2. Molina-Leyva A, Cuenca-Barrales C. Pruritus and Malodour in Patients with Hidradenitis Suppurativa: Impact on Quality of Life and Clinical Features Associated with Symptom Severity. Dermatology (Basel, Switzerland). 2020;236(1):59-65.
  3. Nguyen, T.v.; Damiani, G.; Orenstein, L.; Hamzavi, I.; Jemec, G. Hidradenitis suppurativa: An update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J. Eur. Acad. Dermatol. Venereol. 2021, 35, 50–61.
  4. Alikhan, A.; Lynch, P.J.; Eisen, D.B. Hidradenitis suppurativa: A comprehensive review. J. Am. Acad. Dermatol. 2009, 60, 539–561.
  5. Ingram JR. The epidemiology of hidradenitis suppurativa. Br J Dermatol. 2020;183:990–8.
  6. Garg A, Lavian J, Lin G, Strunk A, Alloo A. Incidence of hidradenitis suppurativa in the United States: a sex- and age-adjusted population analysis. J Am Acad Dermatol. 2017;77:118–22.
  7. Schrader AMR, Deckers IE, van der Zee HH, Boer J, Prens EP. Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity. J Am Acad Dermatol. 2014;71:460–7.
  8. Naik HB, Paul M, Cohen SR, Alavi A, Suàrez-Fariñas M, Lowes MA. Distribution of self-reported Hidradenitis Suppurativa Age at Onset. JAMA Dermatol. 2019;155:971–3.
  9. Pandey A. Essentials of hidradenitis suppurativa: a comprehensive review of diagnostic and treatment perspectives. Ann Med Surg (Lond). 2024;86:5304–13.
  10. Riis PT, Ring HC, Themstrup L, Jemec GB. The role of androgens and estrogens in Hidradenitis Suppurativa - A systematic review. Acta Dermatovenerol Croat. 2016;24:239–49.
  11. WHO Department of Reproductive Health and Research. Report of a technical consultation on sexual health. Geneva: WHO; 2006 (updated 16/03/2014; accesed December 29, 2018). Available at: http://www.who.int/reproductivehealth/publications/sexual_health/defining_sexual_health.pdf?ua=1.
  12. Nazarpour S, Simbar M, Ramezani Tehrani F, Alavi Majd H. Quality of life and sexual function in postmenopausal women. Journal of women & aging. 2018;30(4):299-309.
  13. Nusbaum MR, Hamilton C, Lenahan P. Chronic illness and sexual functioning. American family physician. 2003;67(2):347-354.
  14. Hatzimouratidis, K.; Hatzichristou, D. Sexual dysfunctions: Classifications and definitions. J. Sex. Med. 2007, 4, 241–250.
  15. Park SE, Ma E, Dagenet C, Aleshin MA, Holahan HM, Shi VY, Hsiao JL. Sexual Dysfunction in Chronic Urticaria: A Systematic Review. Dermatol Ther (Heidelb). 2025 Jan;15(1):31-44. doi: 10.1007/s13555-024-01319-5. Epub 2024 Dec 11.
  16. Marella P, Lipner SR. Psoriasis Is Associated With Increased Risk of Psychiatric Disorders and Sexual Dysfunction in a Case-Control Study of 29,912 Patients. Dermatol Pract Concept. 2024 Oct 30;14(4):e2024256.
  17. Rodríguez-Pozo JA, Montero-Vílchez T, Diaz Calvillo P, Sanabria de la Torre R, Ureña Paniego C, Ramirez-Muñoz A, Arias Santiago S. The Impact of Atopic Dermatitis on Sexual Function and Reproductive Desires in Women. Acta Derm Venereol. 2024 Jun 11;104:adv35107. doi: 10.2340/actadv.v104.35107.
  18. McGuigan K, McGuigan CJ. Chronic skin disorders negatively impact women's quality of life and sexual function. Evid Based Nurs. 2019 Oct;22(4):114. doi: 10.1136/ebnurs-2018-103040.
  19. Esmann S, Jemec GBE. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol. 2011;91:328–32.
  20. Cuenca-Barrales C, Montero-Vilchez T, Krajewski PK, Szepietowski JC, Matusiak L, Arias-Santiago S, et al. Sexual dysfunction and quality of life in patients with Hidradenitis Suppurativa and their partners. Int J Environ Res Public Health. 2022;20:389.
  21. Heidarian P, Jalali A, Ghasemianrad M, Jalali R, Ezzati E. Global prevalence of sexual dysfunction in women with skin diseases: a systematic review and meta-analysis. BMC Womens Health. 2025 Mar 6;25(1):101. doi: 10.1186/s12905-025-03625-2.
  22. Dattolo A, Torres M, Frias-Toral E, Paganelli A, Zhang M, Madonna S, Mercurio L, Cucalón G, Garbarino F, Albanesi C, Scala E. Beyond the skin: endocrine, psychological and nutritional aspects in women with hidradenitis suppurativa. J Transl Med. 2025 Feb 10;23(1):167. doi: 10.1186/s12967-025-06175-1.
  23. Caliezi A, Rabufetti A, Hunger R, Wolf R, Seyed Jafari SM. Impact of Hidradenitis Suppurativa on Sexual Quality of Life. J Clin Med. 2025 Jan 30;14(3):910. doi: 10.3390/jcm14030910.
  24. Krajewski PK, Strobel A, Schultheis M, Staubach P, Grabbe S, Hennig K, Matusiak L, von Stebut E, Garcovich S, Bayer H, Heise M, Kirschner U, Nikolakis G, Szepietowski JC. Hidradenitis Suppurativa Is Associated with Severe Sexual Impairment. Dermatology. 2024;240(2):205-215. doi: 10.1159/000536128.
  25. Varney P, Guo W, Brown M, Usmani H, Marquez J, Ayasse M, Kaufmann T, Haughton A. A systematic review and meta-analysis of sexual dysfunction in patients with hidradenitis suppurativa. Int J Dermatol. 2023 Jun;62(6):737-746. doi: 10.1111/ijd.16328.
  26. Smith AD, Curtin GP, Allen NC, Fernandez-Penas P, Varey AH. Management of genital hidradenitis suppurativa and lymphoedema with the restoration of erectile function. Australas J Dermatol. 2022 May;63(2):e184-e186. doi: 10.1111/ajd.13796. Epub 2022 Feb 9.
  27. Cuenca-Barrales C, Montero-Vílchez T, Szepietowski JC, Matusiak L, Molina-Leyva A. Sexual impairment in patients with hidradenitis suppurativa: a systematic review. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):345-352. doi: 10.1111/jdv.16726.
  28. Janse IC, Deckers IE, van der Maten AD, Evers AWM, Boer J, van der Zee HH, Prens EP, Horváth B. Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional study. Br J Dermatol. 2017 Apr;176(4):1042-1047. doi: 10.1111/bjd.14975. Epub 2017 Feb 24.
  29. Zouboulis CC, del Marmol V, Mrowietz U, Prens EP, Tzellos T,Jemec GBE. Hidradenitis Suppurativa/acne inversa: criteria for diag-nosis, severity assessment, classification and disease evaluation. Dermatology. 2015;231(2):184-190.
  30. World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10). Available from: URL: https://icd.who.int/browse10/2016/en Accessed September, 2019.
  31. McCabe MP, Sharlip ID, Atalla E, et al. Definitions of Sexual Dysfunctions in Women and Men: A Consensus Statement From the Fourth International Consultation on Sexual Medicine 2015. The journal of sexual medicine. 2016;13(2):135-143.
  32. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D’Agostino R Jr. The female sexual function index (FSFI): A Multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000; 26: 191-208.
  33. Aygin D, Eti Aslan F. Kadın Cinsel İşlev Ölçeği’nin Türkçeye Uyarlaması. Türkiye Klinikleri J Med Sci. 2005; 25:393-399.
  34. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830.
  35. Turkish Androloji Dernegi IIEF Validation Group. Turkish version of the International Index of Erectile Function (IIEF). 4. Congress of National Sexual Function Disorders “Sexuality; pleasure and pain.” Princess Hotel-Ortaköy, Istanbul, Abstract Book, 2002.
  36. Cuenca-Barrales C, Molina-Leyva A. Risk Factors of Sexual Dysfunction in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study. Dermatology (Basel, Switzerland). 2020;236(1):37-45.
  37. Chew KK, Stuckey B, Bremner A, Earle C, Jamrozik K. Male erectile dysfunction: its prevalence in Western australia and associated sociodemographic factors. The journal of sexual medicine. 2008;5(1):60-69.
  38. Sanchez SC, Chedraui P, Perez-Lopez FR, Ortiz-Benegas ME, Palacios-De Franco Y. Evaluation of sexuality in a Paraguayan mid-aged female urban population using the six-item Female Sexual Function Index. Climacteric: the journal of the International Menopause Society. 2016;19(3):256-260.
  39. Sampogna F, Abeni D, Gieler U, Tomas-Aragones L, Lien L, Titeca G, et al. Impairment of sexual life in 3,485 dermatological outpatients from a multicentre study in 13 European countries. Acta Derm Venereol. 2017;97(4):478–82.
  40. Molina-Leyva A, Salvador-Rodriguez L, Martinez-Lopez A, Ruiz-Carrascosa JC, Arias- Santiago S. Association Between Psoriasis and Sexual and Erectile Dysfunction in Epidemiologic Studies: A Systematic Review. JAMA dermatology. 2019;155(1):98-106.
  41. Rhoden EL, Teloken C, Sogari PR, Vargas Souto CA. The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. International journal of impotence research. 2002;14(4):245-250.
  42. McCabe MP, Sharlip ID, Lewis R, et al. Risk Factors for Sexual Dysfunction Among Women and Men: A Consensus Statement From the Fourth International Consultation on Sexual Medicine 2015. The journal of sexual medicine. 2016;13(2):153-167.
  43. Schneider-Burrus S, Jost A, Peters EMJ, Witte-Haendel E, Sterry W, Sabat R. Association of Hidradenitis Suppurativa With Body Image. JAMA dermatology. 2018;154(4):447- 451.
  44. Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta dermato-venereologica. 2010;90(3):264-268.
  45. Canoui-Poitrine, F.; Le Thuaut, A.; Revuz, J.E.; Viallette, C.; Gabison, G.; Poli, F.; Pouget, F.; Wolkenstein, P.; Bastuji-Garin, S. Identification of three hidradenitis suppurativa phenotypes: Latent class analysis of a cross-sectional study. J. Investig. Dermatol. 2013, 133, 1506–1511.
  46. Collier, E.K.; Parvataneni, R.K.; Lowes, M.A.; Naik, H.B.; Okun, M.; Shi, V.Y.; Hsiao, J.L. Diagnosis and management of hidradenitis suppurativa in women. Am. J. Obstet. Gynecol. 2021, 224, 54–61.
  47. López-Llunell, C.; Romaní, J.; Garbayo-Salmons, P.; Agut-Busquet, E. Vulvar hidradenitis suppurativa: Clinical cross-sectional study of 25 patients. J. Dermatol. 2021, 48, 457–463.
  48. Alavi A, Farzanfar D, Rogalska T, Lowes MA, Chavoshi S. Quality of life and sexual health in patients with hidradenitis suppurativa. Int J Womens Dermatol. 2018;4(2):74–9.
  49. Cuenca-Barrales C, Ruiz-Villaverde R, Molina-Leyva A. Sexual distress in patients with hidradenitis suppurativa: a cross-sectional study. J Clin Med. 2019;8(4):532.
  50. Cuenca-Barrales C, Molina-Leyva A. Sexuality in patients with hidradenitis suppurativa: beliefs, behaviors and needs. Int J Environ Res Public Health. 2020;17(23):8808.
  51. Fisher S, Ziv M. Interviewing women with Hidradenitis Suppurativa-Thematic and Content Analysis. Adv Skin Wound Care. 2022;35:381–4.
  52. El-Sakka AI. Dehydroepiandrosterone and Erectile Function: A Review. World J Mens Health. 2018 Sep;36(3):183–91.
  53. Andersen P, Nielsen R, Sigsgaard V, Jemec G, Riis P. Body image quality of life in patients with hidradenitis suppurativa compared with other dermatological disorders. Acta Derm Venerol 2020;100(8). adv00107-6.
  54. Kurek A, Peters EMJ, Chanwangpong A, Sabat R, Sterry W, Schneider-Burrus S. Profound disturbances of sexual health in patients with acne inversa. J Am Acad Dermatol 2012;67(3):422–8.
  55. Peplau LA, Frederick DA, Yee C, Maisel N, Lever J, Ghavami N. Body image satisfaction in heterosexual, gay, and lesbian adults. Arch Sex Behav 2009;38 (5):713–25.
  56. Milhausen RR, Buchholz AC, Opperman EA, Benson LE. Relationships between body image, body composition, sexual functioning, and sexual satisfaction among heterosexual young adults. Arch Sex Behav 2015;44(6):1621–33.
  57. Jemec GBE, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 1996;35(2):191–4.
  58. Addis IB, Van Den Eeden SK, Wassel-Fyr CL, Vittinghoff E, Brown JS, Thom DH; Re- productive Risk Factors for Incontinence Study at Kaiser Study Group. Sexual activity and function in middle-aged and older women. Obstet Gynecol. 2006 Apr; 107(4): 755– 64.
  59. Sanchez SC, Chedraui P, Perez-Lopez FR, Ortiz-Benegas ME, Palacios-De Franco Y. Evaluation of sexuality in a Paraguayan mid-aged female urban population using the six-item Female Sexual Function Index. Climacteric: the journal of the International Menopause Society. 2016;19(3):256-260.